SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Sonny Liston Synthetic CCD

PatientSonny Liston
Date of birth1989-05-08
IdentifiersMRN HR-BX007-SYN; SSN (made up) 000-07-8853
Document date2026-11-01
AuthorMalcolm Achebe-Whitford, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Establishing care: a high blood pressure reading at a boxing commission check, trauma-informed history, alcohol and drug screening with a safety assessment, and health literacy. Concerns: He wants to keep fighting and needs his blood pressure under control to pass the commission physical; He wants things explained to him out loud, not handed to him on paper; He knows he drinks too much between fights and wants to cut down without being lectured. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Amlodipine 5 mg and valsartan 160 mg combined oral tablet, one tablet each morningOne tablet each morningOral route2026-06-23 to 2026-07-21completedS
Amlodipine 10 mg and valsartan 160 mg combined oral tablet, one tablet each morningOne tablet each morningOral route2026-07-21activeS
Naltrexone 50 mg oral tablet, one tablet each morningOne tablet each morningOral route2026-07-21activeS
Pseudoephedrine 30 mg oral tablet, bought over the counter as a cold tablet, two tablets up to four times a dayTwo tablets up to four times a dayOral route2026-09-05 to 2026-09-08stoppedS
Acetaminophen 500 mg oral tablet, one or two tablets every six hours as needed for aches, no more than four tablets (2 g) a day because he drinksOne or two tablets every six hours as needed; no more than four tablets a dayOral route2026-09-08 to 2026-09-15completedS
Saline nasal spray 0.65%, two sprays in each nostril as neededTwo sprays in each nostril as neededNasal route2026-09-08 to 2026-09-15completedS

Procedures

ProcedureDatesStatusEvidence
Twelve-lead ECG: sinus bradycardia at 56 per minute; voltage criteria for left ventricular hypertrophy without repolarization changes; normal intervals (PR 168 ms, QRS 96 ms, QTc 402 ms)2026-06-09 to 2026-06-09completedS
24-hour ambulatory blood pressure monitoring: daytime average 146/94 mmHg, nighttime average 132/84 mmHg, 24-hour average 142/91 mmHg; nighttime fall 10 percent; confirms hypertension2026-06-17 to 2026-06-18completedS
Transthoracic echocardiogram: mild concentric left ventricular hypertrophy (septum and posterior wall 12 mm), normal chamber size, ejection fraction 60 percent, normal diastolic function (septal e' 10 cm/s), normal valves, aortic root 34 mm2026-06-23 to 2026-06-23completedS

Immunizations

DateVaccineStatusEvidence
2026-08-11Tdap vaccine; no record of an earlier tetanus boostercompletedS
2026-08-11Hepatitis B vaccine (HepB-CpG), dose 1 of 2, recommended for all adults 19 to 59completedS
2026-09-22Hepatitis B vaccine (HepB-CpG), dose 2 of 2completedS
2026-10-20Influenza vaccine, 2026-2027 seasoncompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
ChildhoodPhysical abuse in childhood (beaten regularly by his father) and full-time field work from the age of eightD (CLM-0002)
1954Broken jaw in a professional bout in 1954D (CLM-0005)
February 25, 1964Shoulder injury cited when he did not come out for the seventh round of a title fight in 1964D (CLM-0005)
September 1953Professional boxing since 1953, about 50 bouts as a heavyweight, still activeD (CLM-0005)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
He wants to keep fighting and needs his blood pressure under control to pass the commission physicalactiveS
He wants things explained to him out loud, not handed to him on paperactiveS
He knows he drinks too much between fights and wants to cut down without being lecturedactiveS

Assessment

Most recent measures: Hemoglobin [Mass/volume] in Blood 15.1 on 2026-06-09; MCV [Entitic mean volume] in Red Blood Cells by Automated count 98 on 2026-06-09; Sodium [Moles/volume] in Serum or Plasma 139 on 2026-06-09; Potassium [Moles/volume] in Serum or Plasma 4.4 on 2026-07-21; Creatinine [Mass/volume] in Serum or Plasma 1.1 on 2026-07-21; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 89 on 2026-07-21; Glucose [Mass/volume] in Serum or Plasma 92 on 2026-06-09; Calcium [Mass/volume] in Serum or Plasma 9.6 on 2026-06-09; Hemoglobin A1c/Hemoglobin.total in Blood 5.4 on 2026-06-09; Cholesterol [Mass/volume] in Serum or Plasma 204 on 2026-06-09; Cholesterol in HDL [Mass/volume] in Serum or Plasma 58 on 2026-06-09; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 122 on 2026-06-09; Triglyceride [Mass/volume] in Serum or Plasma 120 on 2026-06-09; Albumin/Creatinine [Mass Ratio] in Urine 18 on 2026-06-09; Thyrotropin [Units/volume] in Serum or Plasma 1.6 on 2026-06-09; Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 31 on 2026-09-22; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 30 on 2026-09-22; Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma 41 on 2026-10-20; Total score [AUDIT] 7 on 2026-10-20; Total score [DAST-10] 0 on 2026-06-09; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 on 2026-10-20; PC-PTSD-5 score [PC-PTSD-5] 1 on 2026-06-09; Total score [AUDIT-C] 4 on 2026-09-22; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 2026-08-11 [S]

Strengths and supports: Strengths and supports: discipline and daily training, physical strength, a sharp memory, his family, his trainer and gym, and the steadiness he says boxing gave him [S]

Problems

ProblemClinical statusVerificationCodeProvenance
High blood pressure readings at a first visit (154/98 mmHg, average of two readings with a large cuff), without a diagnosis of hypertension; out-of-office confirmation neededresolvedconfirmed R03.0S — Synthetic presenting finding; resolved into the diagnosis at the consultation visit when ambulatory monitoring confirmed hypertension.
Hypertension, stage 2, confirmed by 24-hour ambulatory monitoring (daytime average 146/94 mmHg, nighttime 132/84 mmHg), with mild concentric left ventricular hypertrophy on echocardiography and normal kidney function and urine albuminactiveconfirmed I10S — Synthetic modern diagnosis; no hypertension is documented in his life.
Alcohol use disorder, moderate (four DSM-5-TR criteria: drinking more than intended, unsuccessful efforts to cut down, craving, and continued drinking despite its effect on his training, blood pressure and liver tests); AUDIT 16activeconfirmed F10.20S — Synthetic modern diagnosis by interview, anchored to the description of heavy drinking; not a historical diagnosis.
Personal history of physical abuse in childhood (beaten regularly by his father), with heavy field work from the age of eightactiveconfirmed Z62.810S — Synthetic coding of the documented childhood history; physical abuse only.
Does not read or write (no schooling as a child); prefers spoken explanations, pictures and demonstrationsactiveconfirmed Z55.0S — Synthetic coding of the documented literacy, recorded so that care is adapted.
Acute viral upper respiratory infection (common cold) for four days, with blood pressure raised to 158/98 mmHg by an over-the-counter pseudoephedrine cold tablet he could not read the label of; resolvedresolvedconfirmed J06.9S — Synthetic acute illness; not a historical claim.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-06-09Hemoglobin [Mass/volume] in Blood15.1g/dL13.5-17.5 g/dLNormalS
2026-06-09MCV [Entitic mean volume] in Red Blood Cells by Automated count98fL80-100 fLNormalS
2026-06-09Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-06-09Potassium [Moles/volume] in Serum or Plasma4.1mmol/L3.5-5.1 mmol/LNormalS
2026-06-09Creatinine [Mass/volume] in Serum or Plasma1.1mg/dL0.74-1.35 mg/dLNormalS
2026-06-09Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M89mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-06-09Glucose [Mass/volume] in Serum or Plasma92mg/dL70-99 mg/dLNormalS
2026-06-09Calcium [Mass/volume] in Serum or Plasma9.6mg/dL8.6-10.3 mg/dLNormalS
2026-06-09Hemoglobin A1c/Hemoglobin.total in Blood5.4%<=5.6%NormalS
2026-06-09Cholesterol [Mass/volume] in Serum or Plasma204mg/dL<=199 mg/dLHighS
2026-06-09Cholesterol in HDL [Mass/volume] in Serum or Plasma58mg/dL>=40 mg/dLNormalS
2026-06-09Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation122mg/dL<=129 mg/dLNormalS
2026-06-09Triglyceride [Mass/volume] in Serum or Plasma120mg/dL<=149 mg/dLNormalS
2026-06-09Albumin/Creatinine [Mass Ratio] in Urine18mg/g<=29 mg/gNormalS
2026-06-09Thyrotropin [Units/volume] in Serum or Plasma1.6m[IU]/L0.45-4.5 mIU/LNormalS
2026-06-09Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma46U/L10-40 U/LHighS
2026-06-09Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma38U/L7-56 U/LNormalS
2026-06-09Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma88U/L8-61 U/LHighS
2026-06-09Total score [AUDIT]16{score}S
2026-06-09Total score [DAST-10]0{score}S
2026-06-09Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
2026-06-09PC-PTSD-5 score [PC-PTSD-5]1{score}S
2026-07-21Potassium [Moles/volume] in Serum or Plasma4.4mmol/L3.5-5.1 mmol/LNormalS
2026-07-21Creatinine [Mass/volume] in Serum or Plasma1.1mg/dL0.74-1.35 mg/dLNormalS
2026-07-21Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M89mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-07-21Total score [AUDIT-C]7{score}S
2026-09-22Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma31U/L10-40 U/LNormalS
2026-09-22Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma30U/L7-56 U/LNormalS
2026-09-22Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma54U/L8-61 U/LNormalS
2026-09-22Total score [AUDIT-C]4{score}S
2026-10-20Total score [AUDIT]7{score}S
2026-10-20Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma41U/L8-61 U/LNormalS
2026-10-20Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]2{score}S
2026-08-11Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-06-09Body height185cmS
2026-06-09Body weight99kgS
2026-06-09Body mass index (BMI) [Ratio]28.9kg/m2S
2026-06-09Systolic blood pressure154mm[Hg]S
2026-06-09Diastolic blood pressure98mm[Hg]S
2026-06-09Heart rate58/minS
2026-06-09Respiratory rate14/minS
2026-06-09Body temperature36.7CelS
2026-06-09Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-06-23Body height185cmS
2026-06-23Body weight98.6kgS
2026-06-23Body mass index (BMI) [Ratio]28.8kg/m2S
2026-06-23Systolic blood pressure148mm[Hg]S
2026-06-23Diastolic blood pressure96mm[Hg]S
2026-06-23Heart rate56/minS
2026-06-23Respiratory rate14/minS
2026-06-23Body temperature36.6CelS
2026-06-23Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-07-21Body height185cmS
2026-07-21Body weight98kgS
2026-07-21Body mass index (BMI) [Ratio]28.6kg/m2S
2026-07-21Systolic blood pressure136mm[Hg]S
2026-07-21Diastolic blood pressure86mm[Hg]S
2026-07-21Heart rate58/minS
2026-07-21Respiratory rate14/minS
2026-07-21Body temperature36.6CelS
2026-07-21Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-09-22Body height185cmS
2026-09-22Body weight97.2kgS
2026-09-22Body mass index (BMI) [Ratio]28.4kg/m2S
2026-09-22Systolic blood pressure126mm[Hg]S
2026-09-22Diastolic blood pressure78mm[Hg]S
2026-09-22Heart rate56/minS
2026-09-22Respiratory rate14/minS
2026-09-22Body temperature36.6CelS
2026-09-22Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-10-20Body height185cmS
2026-10-20Body weight97kgS
2026-10-20Body mass index (BMI) [Ratio]28.3kg/m2S
2026-10-20Systolic blood pressure122mm[Hg]S
2026-10-20Diastolic blood pressure76mm[Hg]S
2026-10-20Heart rate56/minS
2026-10-20Respiratory rate14/minS
2026-10-20Body temperature36.5CelS
2026-10-20Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-08-11Body height185cmS
2026-08-11Body weight97.6kgS
2026-08-11Body mass index (BMI) [Ratio]28.5kg/m2S
2026-08-11Systolic blood pressure128mm[Hg]S
2026-08-11Diastolic blood pressure80mm[Hg]S
2026-08-11Heart rate56/minS
2026-08-11Respiratory rate14/minS
2026-08-11Body temperature36.6CelS
2026-08-11Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-09-08Body height185cmS
2026-09-08Body weight97.2kgS
2026-09-08Body mass index (BMI) [Ratio]28.4kg/m2S
2026-09-08Systolic blood pressure158mm[Hg]S
2026-09-08Diastolic blood pressure98mm[Hg]S
2026-09-08Heart rate78/minS
2026-09-08Respiratory rate16/minS
2026-09-08Body temperature37.6CelS
2026-09-08Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
2026-06-09Establishing care: a high blood pressure reading at a boxing commission check, trauma-informed history, alcohol and drug screening with a safety assessment, and health literacyfinishedS
2026-06-23Two-week review, seen the same day by cardiology: ambulatory monitoring, echocardiogram, the diagnosis and treatment, and fitness to competefinishedS
2026-07-21Four-week review: blood pressure on treatment, potassium and creatinine, drinking, and medicine teach-backfinishedS
2026-09-22Three-month review: blood pressure, liver tests and drinking on naltrexonefinishedS
2026-10-20Four-month review: blood pressure at goal, AUDIT, and the plan aheadfinishedS
2026-08-11Periodic adult preventive visitfinishedS
2026-09-08Same-day sick visit for a cold and raised blood pressurefinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Confirm the blood pressure out of the office with 24-hour ambulatory monitoring before any diagnosis or medicine; baseline metabolic panel, glucose, lipids, urine albumin, TSH and ECGcompletedGL-AHA-HTN-2025, GL-USPSTF-HTN-2021, GL-CMID-2026S
Cardiology consultation on the same day as the two-week visit: confirm and stage the hypertension, echocardiogram, choice of treatment, and fitness to competecompletedGL-AHA-HTN-2025, GL-ATHLETE-HTN-2015S
Alcohol: nonjudgmental brief intervention with motivational interviewing; a drinking goal he sets himself; medicines (naltrexone, acamprosate or topiramate) explained; AUDIT-C at each follow-up and liver testscompletedGL-NIAAA-CORE, GL-SUD-2021, GL-APA-AUD-2018, GL-USPSTF-ALC-2018S
Safety plan given out loud and as a picture card, with the 988 Suicide & Crisis Lifeline saved in his phone as a voice contact; safety reviewed at every visitcompletedGL-SUICIDE-2024S
Health literacy universal precautions at every visit: plain spoken explanations, one or two key points at a time, teach-back, a picture-based medicine and blood pressure card, consent forms read aloud with time for questions, phone and voice-message reminders instead of letters, and an adult literacy program offered without pressurecompletedGL-AHRQ-HL-2024S
Trauma-informed care: an ACE-informed history in which he chooses what to share, explanation and permission before each part of the examination, a PTSD screen, and counseling offeredcompletedGL-SAMHSA-TIP57-2014, GL-PTSD-2023S
Drug use screening with the DAST-10; naloxone and overdose education if any opioid use is reported or suspectedcompletedGL-USPSTF-DRUG-2020, GL-SAMHSA-NALOXONES
Start a single-pill combination of amlodipine 5 mg and valsartan 160 mg each morning for stage 2 hypertension; potassium and creatinine in two to four weeks; home blood pressure with a talking, large-display monitor; lower-salt eating and alcohol reductioncompletedGL-AHA-HTN-2025, GL-CMID-2026S
Competing: no bouts until blood pressure is controlled, then clearance by the commission physician with a repeat check; no stimulants, decongestants or weight-cut diureticscompletedGL-ATHLETE-HTN-2015S
Raise the combination to amlodipine 10 mg and valsartan 160 mg; start naltrexone 50 mg each morning, with a wallet card saying it blocks opioid pain medicines and a liver test recheck in two monthscompletedGL-AHA-HTN-2025, GL-APA-AUD-2018, GL-SUD-2021S
Cardiovascular risk and preventive care at the preventive visit: lipids, risk estimate, immunizations and one-time screeningscompletedGL-CMID-2026, GL-AHA-HTN-2025S

Goals

GoalTargetStatusOutcomeProvenance
Confirm or rule out hypertension with out-of-office readings before any medicine2026-06-23completedAmbulatory monitoring confirmed stage 2 hypertension (daytime 146/94 mmHg)S
Blood pressure under 130/80 mmHg in the clinic and at home by four months2026-10-20completedClinic 122/76 mmHg; home average 120/76 mmHg on amlodipine 10 mg and valsartan 160 mgS
Drink within the goal he set: no more than 14 drinks a week and no more than 4 on any day, and none in the two weeks before a fight2026-10-20completedAbout 8 drinks a week with no day above 3; AUDIT 7; GGT normalS
Explain his medicines and blood pressure plan back in his own words2026-07-21completedTeach-back correct at four weeks with the picture cardS

Functional Status

Mental Status

Structured synthetic safety assessment on 2026-06-09: current ideation absent, intent absent, plan absent. Outpatient care with a spoken and picture-based safety plan, the 988 Suicide & Crisis Lifeline saved in his phone by voice contact, and a two-week follow-up; safety reviewed at every visit [S]